Faricimab in neovascular age-related macular degeneration: aqueous humor cytokine profiling and biomarker correlations. [PDF]
Wan Z +6 more
europepmc +1 more source
Short-term morphological and functional outcomes of intravitreal faricimab for chorioretinal disorders: a real-world study in a Chinese population. [PDF]
Jin E +5 more
europepmc +1 more source
Two-dose aflibercept 8 mg versus three-dose aflibercept 2 mg loading for treatment-naïve neovascular age-related macular degeneration. [PDF]
Shirakami M +12 more
europepmc +1 more source
Incidence and Clinical Course of Intraocular Inflammation Following Pharmacy-Compounded Intravitreal Aflibercept 8mg for Neovascular AMD: A Real-World Cohort Study. [PDF]
Kucharczuk J +3 more
europepmc +1 more source
Dynamic changes in aqueous humor cytokines and OCTA parameters during aflibercept loading in treatment-naive neovascular age-related macular degeneration. [PDF]
Gui C +6 more
europepmc +1 more source
Bridging Visual Intuition and Chemical Expertise: A Virtual Collaborative Framework for Autonomous Nonadiabatic Dynamics Analysis. [PDF]
Zhu Y +5 more
europepmc +1 more source
Purpose : Previous studies have shown that differences in retinal vascular width are associated with development of early AMD, treatment with anti-vascular Endothelial Growth Factors (Anti VEGF) agents and can be predictive of treatment response; however
Lauren Scott (17221147) +6 more
core
Caveola and Its Resident Proteins, Caveolin-1 and -2, Play Critical Roles in the Pathogenesis of nAMD and PCV. [PDF]
Yu RMC +9 more
europepmc +1 more source
Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. [PDF]
Mansour HA +37 more
europepmc +1 more source
Predictors of 1-year fibrosis in treatment-naïve neovascular age-related macular degeneration: the role of baseline OCTA-derived MNV vessel density. [PDF]
Lin Y +5 more
europepmc +1 more source

